(0.00%) 5 187.67 points
(0.44%) 39 056 points
(-0.18%) 16 303 points
(1.07%) $79.22
(-1.13%) $2.18
(-0.35%) $2 316.10
(0.08%) $27.57
(-0.36%) $984.80
(0.10%) $0.930
(0.09%) $10.91
(0.08%) $0.800
(0.33%) $91.74
0.00% $ 0.0000160
Live Chart Being Loaded With Signals
MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer...
Stats | |
---|---|
Dzisiejszy wolumen | 2 580.00 |
Średni wolumen | 41.00 |
Kapitalizacja rynkowa | 514 912 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 0 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2011-05-19 | Berdugo Gad | Buy | 200 000 | Stock Option (Right to Buy) |
2011-09-24 | Berdugo Gad | Sell | 120 000 | Stock Option (Right to Buy) |
2008-07-07 | Katz Steven | Buy | 0 |
INSIDER POWER |
---|
0.00 |
Last 2 transactions |
Buy: 200 000 | Sell: 120 000 |
Wolumen Korelacja
MabCure, Inc. Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
MabCure, Inc. Korelacja - Waluta/Towar
MabCure, Inc. Finanse
Annual | 2011 |
Przychody: | $500 000 |
Zysk brutto: | $500 000 (100.00 %) |
EPS: | $-0.198 |
FY | 2011 |
Przychody: | $500 000 |
Zysk brutto: | $500 000 (100.00 %) |
EPS: | $-0.198 |
FY | 2010 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-0.0200 |
Financial Reports:
No articles found.
MabCure, Inc.
MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan. MabCure Inc. was founded in 2006 and is based in White Plains, New York.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej